Phase 1b/2 study of rebastinib (DCC-2036) in combination with paclitaxel: Preliminary safety, efficacy, pharmacokinetics and pharmacodynamics in patients with advanced or metastatic solid tumors

被引：2
|
作者：
Janku, Filip [1 ]
Birrer, Michael [2 ]
Richardson, Debra [3 ]
Chu, Christina [4 ]
Goel, Sanjay [5 ]
Su, Ying [6 ]
Matin, Bahar [6 ]
Kuida, Keisuke [6 ]
Ruiz-Soto, Rodrigo [6 ]
Hamilton, Erika Paige [7 ,8 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Alabama Birmingham, Birmingham Comprehens Canc Ctr, Birmingham, AL USA
[3] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Sarah Cannon Res Inst, Oklahoma City, OK USA
[4] Fox Chase Canc Ctr, Havertown, PA USA
[5] Albert Einstein Coll Med, Bronx, NY 10467 USA
[6] Deciphera Pharmaceut LLC, Waltham, MA USA
[7] Sarah Cannon Res Inst, Nashville, TN USA
[8] Tennessee Oncol PLLC, Nashville, TN USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2019年 / 18卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-19-B055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B055
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
    Soria, Jean-Charles
    De Braud, Filippo G.
    Bahleda, Ratislav
    Adamo, Barbara
    Cereda, Roberta
    Camboni, Maria Gabriella
    Robert, Renate
    Isaacson, Jeffrey D.
    Litten, Jason B.
    Allen, Andrew R.
    Rolfe, Lindsey
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] A phase 1 multiple ascending dose study to investigate the safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of KD033 in subjects with metastatic or locally advanced solid tumors.
    Luke, Jason J.
    Olszanski, Anthony J.
    Puzanov, Igor
    Lu, Dan
    Hackett, Adrian
    Martomo, Stella
    Patel, Jeegar
    Schueller, Olivier
    Mora, Alessandro
    Schlitt, Miranda L.
    Li, Linghui
    CANCER RESEARCH, 2021, 81 (13)
  • [23] Phase 1b/2 study to assess the safety, tolerability, and clinical activity of BGB-290 in combination with temozolomide in patients with locally advanced or metastatic solid tumors
    Johnson, M.
    Benson, B.
    Wei, R.
    Brachmann, R.
    Galsky, M. D.
    ANNALS OF ONCOLOGY, 2017, 28
  • [24] Phase 1 Study of Combination Treatment with PTK 787/ZK 222584 and Cetuximab for Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics Analysis
    Langenberg, Marlies H. G.
    Witteveen, Petronella O.
    Lankheet, Nienke A. G.
    Roodhart, Jeanine M. L.
    Rosing, Hilde
    van den Heuvel, Ingeborg J. G. M.
    Beijnen, Jos H.
    Voest, Emile E.
    NEOPLASIA, 2010, 12 (02): : 206 - 213
  • [25] Modakafusp alfa shows intratumoral immune pharmacodynamics (PD) in a subset of patients (pts) in a phase 1b study in advanced/metastatic solid tumors
    Saggu, Gurpanna
    Markman, Janet L.
    Lee, Min Young
    Dunbar, Faith
    Joshi, Adarsh
    Wang, Shining
    Collins, Sabrina
    CANCER RESEARCH, 2024, 84 (07)
  • [26] A phase I study evaluating the safety, efficacy, pharmacokinetics and pharmacodynamics of AL3810 in advanced solid tumors
    Cao, J.
    Li, J.
    Ji, D.
    Shen, W.
    Jiang, L.
    Ma, X.
    Pang, J.
    Kanehisa, A.
    Legrand, F.
    Pallis, A.
    Paux, G.
    Robert, R.
    Chen, X.
    Letecheur, P.
    Qiang, L.
    Ding, J.
    ANNALS OF ONCOLOGY, 2015, 26 : 37 - 37
  • [27] Selinexor in combination with weekly paclitaxel in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multiarm phase 1b study.
    Westin, Shannon Neville
    Fu, Siqing
    Tsimberidou, Apostolia Maria
    Piha-Paul, Sarina Anne Anne
    Akhmedzhanov, Fechukwu
    Yilmaz, Bulent
    McQuinn, Lacey
    Brink, Amanda L.
    Gong, Jing
    Leung, Cheuk Hong
    Lin, Heather Y.
    Hong, David S.
    Pant, Shubham
    Jazaeri, Amir A.
    Gershenson, David Marc
    Sood, Anil K.
    Coleman, Robert L.
    Shah, Jatin J.
    Meric-Bernstam, Funda
    Naing, Aung
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
    Paluri, Ravi
    Madan, Ankit
    Li, Peng
    Jones, Benjamin
    Saleh, Mansoor
    Jerome, Mary
    Miley, Deborah
    Keef, Jennifer
    Robert, Francisco
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 551 - 559
  • [29] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
    Ravi Paluri
    Ankit Madan
    Peng Li
    Benjamin Jones
    Mansoor Saleh
    Mary Jerome
    Deborah Miley
    Jennifer Keef
    Francisco Robert
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 551 - 559
  • [30] Phase 1a study of the safety, pharmacokinetics, and pharmacodynamics of GDC-0919 in patients with recurrent/advanced solid tumors
    Nayak, A.
    Hao, Z.
    Sadek, R.
    Dobbins, R.
    Marshall, L.
    Vahanian, N.
    Ramsey, J.
    Kennedy, E.
    Mautino, M.
    Link, C.
    Lin, R.
    Royer-Joo, S.
    Morrissey, K.
    Mahrus, S.
    McCall, B.
    Pirzkall, A.
    Munn, D.
    Janik, J.
    Khleif, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S69 - S69
12345